| |
| |
Preface | |
| |
| |
Introduction: Letters illustrating clinical aspects of cancer | |
| |
| |
| |
Colon cancer | |
| |
| |
Breast cancer | |
| |
| |
Acute leukemia | |
| |
| |
Lung cancer | |
| |
| |
Kidney cancer | |
| |
| |
Squamous cell cancer | |
| |
| |
Testicular cancer | |
| |
| |
Stomach cancer | |
| |
| |
Melanoma | |
| |
| |
Neuroblastoma | |
| |
| |
Summary | |
| |
| |
| |
The pathology of cancer | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Benign versus malignant tumors | |
| |
| |
| |
The diagnosis of benign and malignant tumors | |
| |
| |
| |
Tumor grading and staging | |
| |
| |
| |
Classification and nomenclature | |
| |
| |
| |
Metastasis | |
| |
| |
| |
Tumor markers | |
| |
| |
| |
How cancer kills | |
| |
| |
| |
Organ failure | |
| |
| |
| |
Obstruction of the gastrointestinal tract, ducts, and hollow organs | |
| |
| |
| |
Cachexia and infection | |
| |
| |
| |
Spontaneous regression | |
| |
| |
| |
Dormancy | |
| |
| |
| |
Initiation | |
| |
| |
| |
Latency | |
| |
| |
| |
Progression to the autonomous state | |
| |
| |
| |
Selection and cellular heterogeneity | |
| |
| |
| |
A developmental concept of cancer | |
| |
| |
| |
Apoptosis | |
| |
| |
| |
Summary | |
| |
| |
| |
Invasion and metastasis | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
The metastatic cascade | |
| |
| |
| |
Disruption of the basement membrane and lytic activity in the extracellular matrix | |
| |
| |
| |
Cell detachment | |
| |
| |
| |
Cell migration and motility | |
| |
| |
| |
Invasion | |
| |
| |
| |
Penetration of the vascular system | |
| |
| |
| |
Cancer cells in the circulation | |
| |
| |
| |
Arrest of circulating cancer cells (stasis) | |
| |
| |
| |
Extravasation, growth of metastases, and metastasis of metastases | |
| |
| |
| |
A multiplicity of genes are associated with metastasis | |
| |
| |
| |
Soil and seed hypothesis of Paget | |
| |
| |
Box: Stephen Paget: No "ploughman" was he! | |
| |
| |
| |
Is metastasis limited to malignant cells? | |
| |
| |
| |
How do we know a metastasis to the liver is not a primary neoplasm of the liver | |
| |
| |
| |
Why study metastasis? | |
| |
| |
| |
Summary | |
| |
| |
| |
Carcinogenesis | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
What is a carcinogen? | |
| |
| |
| |
Carcinogenesis as a multistage process | |
| |
| |
| |
Chemical carcinogenesis | |
| |
| |
| |
Organic compounds | |
| |
| |
| |
Inorganic compounds and asbestos | |
| |
| |
| |
Naturally occurring chemicals | |
| |
| |
| |
Radiation | |
| |
| |
| |
Ultraviolet radiation | |
| |
| |
| |
Ionizing radiation | |
| |
| |
| |
Endogenous ionizing radiation | |
| |
| |
| |
Radon | |
| |
| |
| |
Viral carcinogenesis | |
| |
| |
| |
Endogenous carcinogenesis | |
| |
| |
| |
Metabolism of xenobiotics | |
| |
| |
| |
Host defenses | |
| |
| |
| |
Inducibility of xenobiotic metabolism | |
| |
| |
| |
Metabolic activation of chemical carcinogens | |
| |
| |
| |
Inactivation of chemical carcinogens | |
| |
| |
| |
Systemic distribution of chemical carcinogens | |
| |
| |
| |
Mechanisms for carcinogen suppression/chemoprevention | |
| |
| |
Box: Elizabeth Cavert Miller with husband James | |
| |
| |
| |
Modulation of carcinogenesis | |
| |
| |
| |
Tumor promotion | |
| |
| |
| |
Tumor progression | |
| |
| |
| |
Alternative pathways for carcinogenesis? | |
| |
| |
| |
Federal regulations | |
| |
| |
| |
Summary | |
| |
| |
| |
Genetics and heredity | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Chromosomes and cancer | |
| |
| |
| |
Aneuploidy | |
| |
| |
| |
Euploidy does not preclude genetic change | |
| |
| |
| |
Cancers with chromosomal aberrations | |
| |
| |
| |
Chromosome damage, mutation, and vulnerability to cancer | |
| |
| |
| |
Hereditary cancers | |
| |
| |
| |
Retinoblastoma | |
| |
| |
| |
Wilms tumor | |
| |
| |
| |
Hereditary conditions that increase cancer risk | |
| |
| |
| |
Familial cancer syndromes | |
| |
| |
| |
Colon cancer | |
| |
| |
| |
Breast cancer | |
| |
| |
| |
Prostate cancer | |
| |
| |
| |
Microarray technology as a way of examining many genes simultaneously | |
| |
| |
| |
Summary | |
| |
| |
| |
Cancer-associated genes | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
What is an oncogene? | |
| |
| |
| |
Proto-oncogenes function in signal transduction, cell cycle regulation, differentiation, or programmed cell death (apoptosis) | |
| |
| |
| |
Genetic approaches to delineate proto-oncogene function | |
| |
| |
| |
DNA microarray analysis - global gene expression or genomic profiling | |
| |
| |
| |
Classification of proto-oncogenes/ oncogenes | |
| |
| |
| |
Growth factors and their receptors | |
| |
| |
| |
Nonreceptor tyrosine kinases | |
| |
| |
| |
GTP-binding proteins: ras activation | |
| |
| |
| |
Cytoplasmic serine/threonine kinases | |
| |
| |
| |
Suppression of ras signaling | |
| |
| |
| |
Nuclear signaling | |
| |
| |
| |
Transcriptional activation | |
| |
| |
| |
Regulation of DNA synthesis and the cell cycle | |
| |
| |
| |
Other mechanisms for the regulation of signaling | |
| |
| |
| |
Mechanisms of oncogene activation | |
| |
| |
| |
Carcinogens and oncogene activation | |
| |
| |
| |
Oncogene cooperation | |
| |
| |
| |
Normal cells suppress tumor growth | |
| |
| |
| |
Angiogenesis and tumor development | |
| |
| |
| |
Tumor Suppressor genes | |
| |
| |
| |
The Rb locus | |
| |
| |
| |
p53 suppressor gene | |
| |
| |
| |
Other tumor suppressors | |
| |
| |
| |
Apoptosis and its role in growth regulation | |
| |
| |
| |
Senescence | |
| |
| |
| |
Where pathology meets molecular biology | |
| |
| |
| |
Summary | |
| |
| |
| |
Cancer in nonhuman organisms | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Plant growths | |
| |
| |
| |
Invertebrate animals | |
| |
| |
Box: Yoshio Masui | |
| |
| |
| |
Cancer in selected ectothermic (cold-blooded) vertebrates | |
| |
| |
| |
Fish | |
| |
| |
| |
Amphibia | |
| |
| |
| |
Reptiles | |
| |
| |
Box: John C. Harshbarger | |
| |
| |
| |
Cancer in selected warm-blooded vertebrates | |
| |
| |
| |
Birds | |
| |
| |
| |
Mammals | |
| |
| |
| |
Summary - But try anyway! | |
| |
| |
| |
Epidemiology | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Cancer in fossil humans: A brief digression concerning paleopathology | |
| |
| |
| |
Epidemiology of selected human cancers | |
| |
| |
| |
Lung cancer | |
| |
| |
Box: Alton Ochsner | |
| |
| |
Box: Richard Doll | |
| |
| |
| |
Breast cancer | |
| |
| |
| |
Skin cancer | |
| |
| |
| |
Prostate cancer | |
| |
| |
| |
Colorectal cancer | |
| |
| |
| |
Cervical cancer: "The Beginning of the End" | |
| |
| |
| |
Hodgkin lymphoma | |
| |
| |
| |
Occupational cancers | |
| |
| |
| |
AIDS-related Kaposi's sarcoma | |
| |
| |
| |
What is next? | |
| |
| |
| |
Lifestyle: Is there anything more important? | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Lung cancer is a preventable disease | |
| |
| |
| |
Ultraviolet radiation and that "healthy tan" | |
| |
| |
| |
How to minimize risk for skin cancer | |
| |
| |
| |
The peculiar status of protection by sunscreens | |
| |
| |
| |
Diet, nutrition, and cancer | |
| |
| |
| |
Dietary fiber and colorectal cancer | |
| |
| |
Box: Denis Burkitt | |
| |
| |
| |
Correlations between food substances and cancer prevalence: Significance | |
| |
| |
| |
Dietary fat and obesity | |
| |
| |
| |
Vitamins and cancer | |
| |
| |
| |
Selenium and calcium | |
| |
| |
| |
Non-nutrient organic compounds in food that may protect against cancer | |
| |
| |
| |
American Cancer Society (2002) Guidelines on Diet, Nutrition, and Cancer Prevention | |
| |
| |
| |
Exercise as it relates to cancer | |
| |
| |
| |
A special note about breast cancer | |
| |
| |
| |
Other lifestyle hazards | |
| |
| |
| |
Summary | |
| |
| |
| |
The stem cell basis of cancer treatment: concepts and clinical outcomes | |
| |
| |
| |
| |
Introduction | |
| |
| |
| |
Therapies remaining at the conceptual level | |
| |
| |
| |
Therapies being explored clinically: Differentiation therapy and cytostatic therapy | |
| |
| |
Box: Leland Hartwell, R. Timothy Hunt, and Sir Paul Nurse | |
| |
| |
| |
Eradicating cancer cells - the aim of current cancer therapy | |
| |
| |
| |
Absolute versus fractional cytoreduction | |
| |
| |
Box: Howard Skipper | |
| |
| |
| |
The meaning of "curing cancer" depends on whom you ask | |
| |
| |
| |
The biological basis of multimodality therapy as optimal cancer treatment | |
| |
| |
| |
Biological factors that contribute to treatment success | |
| |
| |
Box: H. Rodney Withers | |
| |
| |
| |
Biological factors that contribute to treatment failure | |
| |
| |
| |
Treatment of intermediate-stage breast cancer as a clinical science success story | |
| |
| |
| |
Summary | |
| |
| |
| |
Oncology: The difficult task of eradicating caricatures of normal tissue renewal in the human patient | |
| |
| |
| |
| |
Surgical oncology | |
| |
| |
| |
Radiation oncology | |
| |
| |
| |
Chemotherapy | |
| |
| |
| |
Directly cytotoxic chemotherapy drugs | |
| |
| |
| |
Reactive chemicals as cytotoxic anticancer drugs | |
| |
| |
| |
Selective cytotoxicity as a screening tool to discover more cytotoxic drugs | |
| |
| |
| |
Indirect tumor cytotoxicity by nutrient deprivation ("antimetabolite therapy") | |
| |
| |
Box: George H. Hitchings, Jr., and Gertrude B. Elion | |
| |
| |
Box: Charles Brenton Huggins | |
| |
| |
| |
Trophic factor therapy to treat hematologic side effects of chemotherapy | |
| |
| |
| |
Therapy that exploits differentiation processes in malignancies | |
| |
| |
| |
Pharmacological issues arising from tumor biology | |
| |
| |
| |
Unknowns, the future, and the emergence of molecular oncology | |
| |
| |
| |
Description of selected tumors | |
| |
| |
| |
| |
Adenocarcinoma of the breast | |
| |
| |
| |
Adenocarcinoma of the prostate | |
| |
| |
| |
Adenocarcinoma of the colon | |
| |
| |
| |
Squamous cell carcinoma | |
| |
| |
| |
Teratocarcinomas | |
| |
| |
| |
Liver cell carcinoma | |
| |
| |
| |
Lung cancer | |
| |
| |
| |
Malignant melanoma | |
| |
| |
| |
Retinoblastoma | |
| |
| |
| |
Neuroblastoma | |
| |
| |
| |
Wilms tumor (nephroblastoma) | |
| |
| |
| |
Sarcomas | |
| |
| |
| |
Lymphoma and leukemia | |
| |
| |
Glossary | |
| |
| |
References | |
| |
| |
Index | |